Results 121 to 130 of about 27,037 (216)

The action mechanism of daptomycin

, 2016
The final publication is available at Elsevier via http://dx.doi.org/10.1016/j.bmc.2016.05.052 © 2016.Daptomycin is a lipopeptide antibiotic produced by the soil bacterium Streptomyces roseosporus that is clinically used to treat severe infections with ...
Taylor, Scott D., Palmer, Michael
core   +1 more source

Pre-clinical experience with daptomycin.

, 2008
Daptomycin is a broad-spectrum, bactericidal agent active against Gram-positive bacteria, acting largely and unusually through membrane depolarization.
Hawkey, Peter
core   +1 more source

Comparative Activity of Daptomycin and Teicoplanin against Enterococci Isolated from Blood and Urine

Canadian Journal of Infectious Diseases, 1992
The authors compared the activity of daptomycin with that of ampicillin, penicillin, teicoplanin and vancomycin against 304 strains of Enterococcus species isolated from blood and urine.
Kevin R Forward, Patricia DeGagne, Kathryn R Bartlett, Godfrey K Harding   +3 more
doaj   +1 more source

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol

, 2014
Paul Zarogoulidis,1 Ioannis Kioumis,1 Sofia Lampaki,1 John Organtzis,1 Konstantinos Porpodis,1 Dionysios Spyratos,1 Georgia Pitsiou,1 Dimitris Petridis,2 Athanasia Pataka,1 Haidong Huang,3 Qiang Li,3 Lonny Yarmus,4 Wolfgang Hohenforst-Schmidt,5 Nikolaos ...
Spyratos D, Pataka A, Organtzis J, Huang H, Kioumis I, Lampaki S, Yarmus L, Li Q, Hohenforst-Schmidt W, Pitsiou G, Zarogoulidis K, Pezirkianidis N, Porpodis K, Petridis D, Zarogoulidis P   +14 more
core  

Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus

, 2020
The combination of vancomycin or daptomycin plus ceftaroline has showed synergistic results in vitro. This study aimed to investigate in vitro synergy of vancomycin or daptomycin plus ceftaroline for seven patients with daptomycin non-susceptible ...
Herc, Erica, Sundaram, Ayesha, Hutton, Mary A, Perri, Mary B, Zervos, Marcus J   +4 more
core  

Daptomycin-Induced Acute Eosinophilic Pneumonia: Late Onset and Quick Recovery

Case Reports in Pulmonology, 2017
Background. Daptomycin is a cyclic lipopeptide antibiotic that provides great coverage for gram positive cocci. From the early years of daptomycin use, concerns were raised regarding the pulmonary side effects of daptomycin and potential development of ...
Mohamad Rachid, Khansa Ahmad, Meghan Saunders-Kurban, Aelia Fatima, Aditya Shah, Anas Nahhas   +5 more
doaj   +1 more source

Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus

, 2012
Mao Hagihara1, Takumi Umemura1, Takeshi Mori1,2, Hiroshige Mikamo11Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan; 2Division of Pharmaceutical Science, Faculty of Pharmacy, Meijo ...
Hagihara M, Mikamo H, Mori T, Umemura T
core  

Genetic Basis for Daptomycin Resistance in Enterococci

, 2011
The emergence of multidrug-resistant enterococci as a leading cause of hospital-acquired infection is an important public health concern. Little is known about the genetic mechanisms by which enterococci adapt to strong selective pressures, including the
Jared Silverman, Kelli L. Palmer, Anu Daniel, Crystal Hardy, Michael S. Gilmore   +4 more
core   +1 more source

Genetic Basis for Daptomycin Resistance in Enterococci

, 2018
The emergence of multidrug-resistant enterococci as a leading cause of hospital-acquired infection is an important public health concern. Little is known about the genetic mechanisms by which enterococci adapt to strong selective pressures, including the
Hardy, C., Silverman, J., Palmer, K. L., Gilmore, Michael, Daniel, A.   +4 more
core   +1 more source

Native valve endocarditis caused by corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?

, 2012
We describe a patient who developed Corynebacterium striatum native valve endocarditis after receiving two 6-week courses of daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Diaz, Lorena, Tran, Truc T., Lewis, Cole T., Kaplan, Heidi B., Wanger, Audrey R., Beral, Valerie, Arias, César A., Jaijakul, Siraya, panesso, diana   +8 more
core   +1 more source